PUBLISHER: The Business Research Company | PRODUCT CODE: 1415737
PUBLISHER: The Business Research Company | PRODUCT CODE: 1415737
Diverticulitis Disease Global Market Report 2024
“Diverticulitis Disease Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on diverticulitis disease market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for diverticulitis disease? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The diverticulitis disease market global report ” from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Scope
Markets Covered:
- 1) By Type: Uncomplicated; Complicated
- 2) By Diagnosis: Computed Tomography (CT) Scan; Ultrasound; Urine Test; Blood Test
- 3) By Treatment: Medications; Surgery; Supportive care; Penicillin Antibiotic; Antibiotics; Dietary Supplements; Intravenous (IV) Fluids
- 4) By End-User: Specialty Centers; Hospitals; Research centers
- Companies Mentioned: Pfizer Inc.; Johnson and Johnson; F. Hoffmann-La Roche AG; Merck & Co. Inc.; AbbVie Inc.
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Executive Summary
Diverticulitis disease is a medical condition marked by inflammation or infection of small pouches that develop in the walls of the colon or large intestine. Symptoms may encompass lower abdominal pain, constipation, diarrhea, and rectal bleeding.
The disease is categorized into two main types sush as uncomplicated and complicated. Uncomplicated diverticulitis refers to the inflammation or infection of these small pouches, known as diverticula, within the colon walls. Various diagnostic methods such as computed tomography (CT) scans, ultrasounds, urine tests, and blood tests are employed. Treatment options encompass medications, surgery, supportive care, penicillin antibiotics, other antibiotics, dietary supplements, and intravenous (IV) fluids. These treatments are utilized by diverse end-users, including specialty centers, hospitals, and research centers.
The diverticulitis disease market research report is one of a series of new reports from The Business Research Company that provides diverticulitis disease market statistics, including diverticulitis disease industry global market size, regional shares, competitors with a diverticulitis disease market share, detailed diverticulitis disease market segments, market trends and opportunities and any further data you may need to thrive in the diverticulitis disease industry. This diverticulitis disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The diverticulitis disease market size has grown rapidly in recent years. It will grow from $1.68 billion in 2023 to $1.85 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, dietary habits, obesity, advancements in medical imaging.
The diverticulitis disease market size is expected to see strong growth in the next few years. It will grow to $2.65 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. The growth in the forecast period can be attributed to colonoscopy and endoscopy, increased awareness, minimally invasive procedures, personalized medicine. Major trends in the forecast period include preventive measures, enhanced diagnostic tools, collaborative care models, healthcare policy changes.
The increasing need for drugs and treatments for digestive disorders is projected to be a significant factor propelling the expansion of the diverticulitis disease market in the foreseeable future. Digestive disorders encompass a broad spectrum of conditions affecting the digestive system, responsible for the breakdown and absorption of nutrients from food. These disorders, including colorectal cancer, can heighten the risk of diverticulitis by contributing to the formation of diverticula and fostering bacterial stagnation in the colon's pouches. For instance, as of September 2022, the International Agency for Research on Cancer estimated that by 2040, there would be an annual occurrence of 3.2 million new cases and 1.6 million deaths attributed to colorectal cancer, signifying a notable increase from 1.9 million newly diagnosed patients and 930,000 deaths in 2020. Consequently, the rising demand for drugs and treatments for digestive disorders serves as a driving force behind the growth of the diverticulitis disease market.
The escalating prevalence of inflammatory bowel diseases (IBD) is anticipated to be a significant driver for the growth of the diverticulitis disease market in the coming years. Inflammatory bowel disease refers to a group of chronic inflammatory disorders primarily impacting the gastrointestinal (GI) tract. It is noteworthy that diverticulitis can initially present symptoms akin to IBD, and there is evidence of low-grade chronic inflammation in individuals with diverticula. The prevailing theory is that diverticulitis arises from mucosal inflammation induced by immune system activation. For instance, as reported by BioMed Central Ltd. in May 2021, it is projected that between 2020 and 2035, there will be an estimated 69 thousand cases of inflammatory bowel disease in Iran, 220 thousand cases in the Middle East, 2.2 million cases in India, and 4.5 million cases in East Asia. Consequently, the increasing incidence of inflammatory bowel diseases is a key driver behind the growth of the diverticulitis disease market.
Major players in the diverticulitis disease market are Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Company, Cipla Limited, Hikma Pharmaceuticals PLC, Endo Pharmaceuticals, Aspen Pharmacare, Zydus Lifesciences, Lupin Limited, Glenmark Pharmaceuticals, Alkem Laboratories, Torrent Pharmaceuticals Ltd.
A deficit in disease awareness is expected to impede the growth of the diverticulitis disease market in the coming years. Insufficient knowledge about diverticulitis among the general population can lead to delayed diagnosis and treatment, potentially exacerbating the condition. For example, as of June 2023, the National Library of Medicine reported that individuals experiencing symptoms like pain in the lower left abdomen, fever, nausea and vomiting, diarrhea, and loss of appetite often delay seeking care due to feelings of embarrassment or a fear of potentially undergoing gastrointestinal surgery with a colostomy bag as their sole treatment option. Consequently, the lack of awareness about the disease acts as a hindrance to the growth of the diverticulitis disease market.
Prominent companies in the diverticulitis disease market are actively engaged in the development of innovative drugs and securing regulatory approvals, a strategic move to bolster their market position. This endeavor holds the potential to yield more effective treatment options for diverticulitis, thereby mitigating the risk of complications and enhancing patient outcomes. For example, in April 2023, the United States Food and Drug Administration, a federal organization based in the US, granted approval for Seres' microbiota drug tailored for recurrent gut infections. This drug is designed to address recurring gut infections and preempt the resurgence of Clostridioides difficile (C. diff.) infections in adults aged 18 and above.
Surge In Healthcare Expenditure Drives Advancements In Diverticulitis Disease Care
North America was the largest region in the diverticulitis disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in diverticulitis disease report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the diverticulitis disease market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The diverticulitis disease market consists of revenues earned by entities by providing diagnostic services, pain management, nutritional therapy and follow-up services. The market value includes the value of related goods sold by the service provider or included within the service offering. The diverticulitis disease market also includes sales of antibiotics, dietary supplements, high-fiber foods and pain medications. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Table of Contents
1. Executive Summary
2. Diverticulitis Disease Market Characteristics
3. Diverticulitis Disease Market Trends And Strategies
4. Diverticulitis Disease Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On The Market
- 4.2. Ukraine-Russia War Impact On The Market
- 4.3. COVID-19 Impact On The Market
5. Global Diverticulitis Disease Market Size and Growth
- 5.1. Global Diverticulitis Disease Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
- 5.2. Global Diverticulitis Disease Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
- 5.3. Global Diverticulitis Disease Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)
6. Diverticulitis Disease Market Segmentation
- 6.1. Global Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Uncomplicated
- Complicated
- 6.2. Global Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Computed Tomography (CT) Scan
- Ultrasound
- Urine Test
- Blood Test
- 6.3. Global Diverticulitis Disease Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Medications
- Surgery
- Supportive care
- Penicillin Antibiotic
- Antibiotics
- Dietary Supplements
- Intravenous (IV) Fluids
- 6.4. Global Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- Specialty Centers
- Hospitals
- Research centers
7. Diverticulitis Disease Market Regional And Country Analysis
- 7.1. Global Diverticulitis Disease Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 7.2. Global Diverticulitis Disease Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Diverticulitis Disease Market
- 8.1. Asia-Pacific Diverticulitis Disease Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.3. Asia-Pacific Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 8.4. Asia-Pacific Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Diverticulitis Disease Market
- 9.1. China Diverticulitis Disease Market Overview
- 9.2. China Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.3. China Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
- 9.4. China Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Diverticulitis Disease Market
- 10.1. India Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.2. India Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 10.3. India Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Diverticulitis Disease Market
- 11.1. Japan Diverticulitis Disease Market Overview
- 11.2. Japan Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.3. Japan Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 11.4. Japan Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Diverticulitis Disease Market
- 12.1. Australia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.2. Australia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 12.3. Australia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Diverticulitis Disease Market
- 13.1. Indonesia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.2. Indonesia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 13.3. Indonesia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Diverticulitis Disease Market
- 14.1. South Korea Diverticulitis Disease Market Overview
- 14.2. South Korea Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.3. South Korea Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 14.4. South Korea Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Diverticulitis Disease Market
- 15.1. Western Europe Diverticulitis Disease Market Overview
- 15.2. Western Europe Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.3. Western Europe Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 15.4. Western Europe Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Diverticulitis Disease Market
- 16.1. UK Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.2. UK Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 16.3. UK Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Diverticulitis Disease Market
- 17.1. Germany Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.2. Germany Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 17.3. Germany Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Diverticulitis Disease Market
- 18.1. France Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.2. France Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 18.3. France Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Diverticulitis Disease Market
- 19.1. Italy Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.2. Italy Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 19.3. Italy Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Diverticulitis Disease Market
- 20.1. Spain Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.2. Spain Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 20.3. Spain Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Diverticulitis Disease Market
- 21.1. Eastern Europe Diverticulitis Disease Market Overview
- 21.2. Eastern Europe Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.3. Eastern Europe Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 21.4. Eastern Europe Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Diverticulitis Disease Market
- 22.1. Russia Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.2. Russia Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 22.3. Russia Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Diverticulitis Disease Market
- 23.1. North America Diverticulitis Disease Market Overview
- 23.2. North America Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.3. North America Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 23.4. North America Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Diverticulitis Disease Market
- 24.1. USA Diverticulitis Disease Market Overview
- 24.2. USA Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.3. USA Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 24.4. USA Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Diverticulitis Disease Market
- 25.1. Canada Diverticulitis Disease Market Overview
- 25.2. Canada Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.3. Canada Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 25.4. Canada Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Diverticulitis Disease Market
- 26.1. South America Diverticulitis Disease Market Overview
- 26.2. South America Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.3. South America Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 26.4. South America Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Diverticulitis Disease Market
- 27.1. Brazil Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.2. Brazil Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 27.3. Brazil Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Diverticulitis Disease Market
- 28.1. Middle East Diverticulitis Disease Market Overview
- 28.2. Middle East Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.3. Middle East Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 28.4. Middle East Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Diverticulitis Disease Market
- 29.1. Africa Diverticulitis Disease Market Overview
- 29.2. Africa Diverticulitis Disease Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.3. Africa Diverticulitis Disease Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
- 29.4. Africa Diverticulitis Disease Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Diverticulitis Disease Market Competitive Landscape And Company Profiles
- 30.1. Diverticulitis Disease Market Competitive Landscape
- 30.2. Diverticulitis Disease Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Johnson and Johnson
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche AG
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co. Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. AbbVie Inc.
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 30.2.1. Pfizer Inc.
31. Diverticulitis Disease Market Other Major And Innovative Companies
- 31.1. Bayer AG
- 31.2. Novartis AG
- 31.3. Sanofi S.A.
- 31.4. Bristol-Myers Squibb Company
- 31.5. AstraZeneca plc
- 31.6. Abbott Laboratories
- 31.7. GlaxoSmithKline plc
- 31.8. Takeda Pharmaceutical Company Limited
- 31.9. Eli Lilly and Company
- 31.10. Amgen Inc.
- 31.11. Viatris Inc.
- 31.12. Teva Pharmaceutical Industries Ltd.
- 31.13. Astellas Pharma
- 31.14. Eisai Co. Ltd.
- 31.15. Sun Pharmaceutical Industries Ltd.
32. Global Diverticulitis Disease Market Competitive Benchmarking
33. Global Diverticulitis Disease Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Diverticulitis Disease Market
35. Diverticulitis Disease Market Future Outlook and Potential Analysis
- 35.1 Diverticulitis Disease Market In 2028 - Countries Offering Most New Opportunities
- 35.2 Diverticulitis Disease Market In 2028 - Segments Offering Most New Opportunities
- 35.3 Diverticulitis Disease Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
